graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells


Vein graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells


Zhang L, Brian L, Freedman NJ (Duke Univ Med Ctr, Durham, NC) J Vasc Surg 56:1390-1397, 2012§



J. Cullen, PhD



Evidence Ranking


E



Expert Rating


3



Abstract





Results


The agonist for CXCR4 is expressed by cells in the arterializing vein graft. Vein graft neointimal hyperplasia was reduced by reducing CXCR4 activity in vein graft-extrinsic cells, but not in vein graft-intrinsic cells: the rank order of neointimal hyperplasia was WT/WT ≈ Cxcr4−/+/WT > WT/Cxcr4−/+ ≈ Cxcr4−/+/Cxcr4−/+; CXCR4 deficiency in graft-extrinsic cells reduced neointimal hyperplasia by 39% to 47% (P < .05). Vein graft medial area was equivalent in all grafts except Cxcr4−/+/Cxcr4−/+, in which the medial area was 60% ± 20% greater (P < .05). Vein graft re-endothelialization was indistinguishable among all three vein graft groups. However, the prevalence of medial leukocytes was 40% ± 10% lower in Cxcr4−/+/Cxcr4−/+ than in WT/WT vein grafts (P < .05), and the prevalence of smooth muscle actin-positive cells was 45% ± 20% higher (P < .05).

Stay updated, free articles. Join our Telegram channel

Apr 3, 2017 | Posted by in CARDIOLOGY | Comments Off on graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells

Full access? Get Clinical Tree

Get Clinical Tree app for offline access